# A Study of HIV-Disease Development in Aging

> **NCT00006144** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 90 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Lopinavir/Ritonavir
- **DRUG:** Emtricitabine
- **DRUG:** Stavudine

## Key facts

- **NCT ID:** NCT00006144
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 90 (—)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006144, "A Study of HIV-Disease Development in Aging". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00006144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*